Lamb Model of RSV Infection

Area of Science:

• Virology
• Infectious Diseases
• Preclinical Research

Background:

• Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in vulnerable populations.
• Existing animal models are used to test RSV therapeutics, but limitations exist.
• The lamb model presents unique advantages for studying RSV.

Purpose of the Study:

• To detail the protocol for utilizing the lamb model in RSV infection studies.
• To highlight the suitability of the lamb model for preclinical evaluation of antiviral agents and vaccines.

Main Methods:

• Infection of lambs with human RSV.
• Detailed explanation of the experimental protocol.
• Description of assays to assess infection severity.

Main Results:

• The lamb model mimics human infant respiratory system characteristics.
• Lambs are susceptible to human RSV, allowing for relevant infection studies.
• The model facilitates evaluation of multiple therapeutic approaches and experimental designs.

Conclusions:

• The lamb model is a robust preclinical model for RSV research.
• It enables comprehensive assessment of antiviral compounds and vaccine efficacy.
• This model supports the advancement of RSV therapeutics towards human clinical trials.